SCHEMBL31205643

SCHEMBL31205643

Cc1ccc([C@@H]2CC(O)ON2C(=O)OC(C)(C)C)cn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.37
WNT3A P56704 1/20 0.35
GPR119 Q8TDV5 8/20 0.35
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DDB1 Q16531 1/20 0.34
CRBN Q96SW2 1/20 0.34
POLB P06746 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
SSTR4 P31391 2/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25296814 0.88 ALDH1A1 (0.36) TSHRDDB1CRBNPOLB
SCHEMBL30547542 0.88 ALDH1A1 (0.36) TSHRDDB1CRBNPOLB
SCHEMBL25816524 0.83 KMT2A (0.35) GPR119MEN1MAPTTSHRKMT2A
SCHEMBL18921291 0.81 DGAT1 (0.38) DGAT1WNT3AGPR119MEN1MAPT
SCHEMBL29966718 0.81 DGAT1 (0.38) DGAT1WNT3AGPR119MEN1MAPT
SCHEMBL31205916 0.81 DPP4 (0.34) GPR119MAPTTSHRPOLBCYP1A2
SCHEMBL25816371 0.81 GPR119 (0.36) GPR119SMN1; SMN2CYP3A4
SCHEMBL29966472 0.80 DGAT1 (0.39) DGAT1WNT3AGPR119MEN1MAPT
SCHEMBL30547503 0.80 DGAT1 (0.39) DGAT1WNT3AGPR119MEN1MAPT
SCHEMBL29048248 0.80 DGAT1 (0.39) DGAT1WNT3AGPR119MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709723-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2026-03-18 EP disclosed
WO-2024233544-A1 ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF GENZYME CORPORATION (US) 2024-11-14 WO disclosed